ClinicalTrials.Veeva

Menu

Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions

H

Health Beacons

Status

Withdrawn

Conditions

Non-palpable Breast Lesions

Treatments

Device: RFID Tag (Health Beacon)

Study type

Observational

Funder types

Industry

Identifiers

NCT01574664
S10-001

Details and patient eligibility

About

The goal of this investigation is to obtain clinical data to show the Health Beacons Radiofrequency Identification (RFID) Localization System is safe and performs as intended as a localization device for marking and retrieving a non-palpable surgical target from the breast.

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have had stereotactic or ultrasound-guided biopsy with marker placement
  • Have a lesion or biopsy marker that is visible under ultrasound
  • Have surgical target < 6 cm from the skin when lying supine
  • Have a discreet surgical target
  • Have a lesion in which the center/focal area is defined
  • Be at least 18 years of age or older

Exclusion criteria

  • Have a palpable lesion that does not require localization
  • Require more than one localization needle for localization of the surgical target
  • Have undergone previous open surgical biopsy or lumpectomy in the operative breast
  • Have an implant in the operative breast
  • Have a cardiac pacemaker or defibrillator device

Trial design

0 participants in 1 patient group

Subjects scheduled to undergo lumpectomy
Treatment:
Device: RFID Tag (Health Beacon)

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems